|
Market Closed -
Swiss Exchange
18:31:30 14/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 122.66 CHF | +2.82% |
|
+2.20% | +11.92% |
| 12:58pm | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 10-13 | Major drugmakers turn to China for licensing deals | RE |
| Market Cap | 272B 243B 227B 206B 387B 25,851B 390B 2,716B 1,063B 13,444B 1,023B 1,000B 43,142B | P/E 2026 * |
20.1x | P/E 2027 * | 16.8x |
|---|---|---|---|---|---|
| Enterprise Value | 304B 272B 253B 229B 432B 28,852B 435B 3,032B 1,187B 15,005B 1,142B 1,116B 48,150B | EV / Sales 2026 * |
5.27x | EV / Sales 2027 * | 4.91x |
| Free-Float |
91.66% | Yield 2026 * |
3.02% | Yield 2027 * | 3.15% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
CBOE
| 0QLR | Real-time | |
|
London S.E.
| 0QLR | Delayed | |
|
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
Xetra
| NOT | Delayed | |
|
Tradegate
| NOT | Real-time | |
|
Xetra
| NOT | End-of-day quote | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
OTC Markets
| NVSEF | Delayed | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Boerse Muenchen
| NOT | Real-time | |
|
Börse Stuttgart
| NOT | Delayed | |
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
CBOE
| 0QLR | Real-time | |
|
Wiener Boerse
| NOVN | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | +2.62% | ||
| 1 week | +2.20% | ||
| Current month | +2.25% | ||
| 1 month | +7.67% | ||
| 3 months | +0.20% | ||
| 6 months | +1.98% | ||
| Current year | +11.92% |
| 1 week | 117.26 |  | 122.66 |
| 1 month | 112.46 | | 122.66 |
| Current year | 107.68 | | 132.68 |
| 1 year | 97.05 | | 132.68 |
| 3 years | 81.1 | | 132.68 |
| 5 years | 72.84 | | 132.68 |
| 10 years | 65.09 | | 132.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 14/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/18/26 A | Sell | -5,200 | 0.0003% | |||
| 5/4/26 A | Sell | 6,800 | 0.0003% | |||
| 2/17/26 A | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.82% | +2.20% | +17.90% | +40.67% | 272B | |
| +3.90% | +1.97% | +49.22% | +96.58% | 1,040B | |
| +1.41% | -2.36% | +32.22% | +60.19% | 599B | |
| +3.38% | +4.35% | +23.58% | +92.33% | 485B | |
| +3.22% | +2.23% | +72.34% | +40.17% | 350B | |
| +3.09% | +3.03% | +29.59% | +47.09% | 345B | |
| +3.56% | +1.15% | -3.28% | +12.29% | 244B | |
| +3.04% | +3.04% | +44.84% | +48.36% | 223B | |
| +2.68% | +3.27% | +28.00% | +91.48% | 183B | |
| -0.27% | +0.81% | -29.03% | -63.79% | 170B | |
| Average | +2.64% | +2.59% | +26.54% | +46.54% | 391.28B | |
| Weighted average by Cap. | +2.92% | +2.40% | +33.67% | +61.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.66B 51.51B 48.01B 43.52B 81.91B 5,473B 82.55B 575B 225B 2,846B 217B 212B 9,134B | 61.35B 54.8B 51.08B 46.31B 87.16B 5,824B 87.84B 612B 240B 3,029B 230B 225B 9,719B |
| Net income | 14.59B 13.03B 12.15B 11.01B 20.72B 1,385B 20.89B 145B 56.96B 720B 54.78B 53.58B 2,311B | 16.19B 14.46B 13.48B 12.22B 23B 1,537B 23.18B 161B 63.21B 799B 60.8B 59.46B 2,565B |
| Net Debt | 31.62B 28.24B 26.32B 23.87B 44.91B 3,001B 45.27B 315B 123B 1,561B 119B 116B 5,008B | 28.66B 25.6B 23.86B 21.63B 40.71B 2,720B 41.03B 286B 112B 1,415B 108B 105B 4,540B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/10/26 | CHF 122.66 | +2.82% | 2,656,394 |
| 13/10/26 | CHF 119.30 | -0.55% | 3,008,571 |
| 12/10/26 | CHF 119.96 | +0.72% | 2,107,041 |
| 09/10/26 | CHF 119.10 | +1.17% | 1,772,212 |
| 08/10/26 | CHF 117.72 | -1.92% | 3,863,359 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
